Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04445038
Status:
UNKNOWN
Last Update Posted:
2021-01-28
First Post:
2020-06-21
Brief Title:
Safety Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma |
Keywords: